Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 3/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | DNTT | P04053 | 2/20 | 0.30 |
| ▸ | POLB | P06746 | 2/20 | 0.30 |
| ▸ | POLA1 | P09884 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29275521 | 0.95 | LMNA (0.33) | OPRK1ALDH1A1LMNAPOLB | |
| SCHEMBL29275519 | 0.95 | SMN1; SMN2 (0.32) | OPRK1OPRD1ALDH1A1LMNADNTT | |
| SCHEMBL25206845 | 0.84 | LMNA (0.34) | OPRK1ALDH1A1LMNAPOLB | |
| SCHEMBL25197921 | 0.83 | USP2 (0.32) | — | |
| SCHEMBL25220587 | 0.82 | GAA (0.36) | ALDH1A1LMNA | |
| SCHEMBL25228368 | 0.80 | ALDH1A1 (0.32) | OPRK1ALDH1A1LMNAPOLB | |
| SCHEMBL29275511 | 0.78 | — | — | |
| SCHEMBL25239408 | 0.78 | OPRK1 (0.30) | OPRK1 | |
| SCHEMBL25201693 | 0.77 | CYP19A1 (0.30) | ALDH1A1 | |
| SCHEMBL3751684 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250034074-A1 | PROCESS FOR PREPARING A CYCLIC DIENE | FIRMENICH SA (CH) | 2025-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250034074-A1 | PROCESS FOR PREPARING A CYCLIC DIENE | DHPS, FDFT1, CYP17A1 | OPRK1 2311/4885OPRD1 2653/4885ALDH1A1 246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.